CureVac gets an early date in Covid-19 vaccine patent case with Pfizer/BioNTech
Pharmaceutical Technology
MAY 22, 2023
The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. CureVac’s lawsuits add to a complex legal landscape for Pfizer/BioNTech that already includes ones from Moderna.
Let's personalize your content